Answers are grounded in this paper and cite their sources.
This review explores some of the evidence regarding the benefits of various approaches to haemodialysis, both low- and high-flux, and haemodiafiltration, including high-volume haemodiafiltration, for patients receiving renal replacement therapy (RRT) for end-stage kidney disease. Peter Ellis examines, and where available, compares the evidence for the survival and other morbidity benefits of each RRT modality.
No takes yet. Share an insight, caveat, or question.
Peter Ellis (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: